CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-13 | LINDAHL RICHARD S EVP, Chief Financial Officer | Grant or award · Employee Stock Options (Right to Buy) | +125,000 | 305,944 | ||
| 2024-03-13 | Hartzel William SVP, Bioservices | Grant or award · Employee Stock Options (Right to Buy) | +125,000 | 152,211 | ||
| 2024-03-05 | Hartzel William SVP, Bioservices | Shares withheld for taxes | −346 | $3.41 | $1K | 34,939 |
| 2024-03-01 | Glessner Coleen EVP, Quality & Ethics, and CPL | Shares withheld for taxes | −381 | $3.39 | $1K | 164,968 |
| 2024-03-01 | Williams Paul Anthony SVP, Products Business | Shares withheld for taxes | −137 | $3.39 | $464 | 24,882 |
| 2024-03-01 | LINDAHL RICHARD S EVP, Chief Financial Officer | Shares withheld for taxes | −684 | $3.39 | $2K | 158,742 |
| 2024-03-01 | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Shares withheld for taxes | −703 | $3.39 | $2K | 173,758 |
| 2024-02-29 | Williams Paul Anthony SVP, Products Business | Shares withheld for taxes | −450 | $3.23 | $1K | 25,019 |
| 2024-02-29 | LINDAHL RICHARD S EVP, Chief Financial Officer | Shares withheld for taxes | −9,037 | $3.23 | $29K | 159,426 |
| 2024-02-29 | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Shares withheld for taxes | −4,103 | $3.23 | $13K | 174,461 |
| 2024-02-23 | Williams Paul Anthony SVP, Products Business | Shares withheld for taxes | −105 | $2.74 | $288 | 25,469 |
| 2024-02-23 | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Shares withheld for taxes | −229 | $2.74 | $627 | 178,564 |
| 2024-02-23 | LINDAHL RICHARD S EVP, Chief Financial Officer | Shares withheld for taxes | −517 | $2.74 | $1K | 168,463 |
| 2024-02-21 | LINDAHL RICHARD S EVP, Chief Financial Officer | Returned to the company | −4,012 | $2.71 | $11K | 168,980 |
| 2023-11-13 | Williams Paul Anthony SVP, Products Business | Shares withheld for taxes | −566 | $1.82 | $1K | 25,574 |
| 2023-11-11 | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Shares withheld for taxes | −413 | $2.00 | $826 | 178,793 |
| 2023-11-11 | Hartzel William SVP, Bioservices | Shares withheld for taxes | −632 | $2.00 | $1K | 35,285 |
| 2023-10-03 | Fowler Neal Franklin Director | Grant or award | +118,670 | 118,670 | ||
| 2023-10-03 | DeGolyer Donald W Director | Grant or award | +118,670 | 118,670 | ||
| 2023-07-08 | Williams Paul Anthony SVP, Products Business | Shares withheld for taxes | −85 | 26,140 |
Page 10 of 17 · 330 trades